Exhibit 32.1

                            CERTIFICATION PURSUANT TO

                             18 U.S.C. SECTION 1350,

                             AS ADOPTED PURSUANT BY

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly  Report of Evolve Oncology Inc., on Form 10-QSB
for the period ending March 31, 2005 as filed with the  Securities  and Exchange
Commission on the date hereof (the "Report" ), the undersigned,  Nigel Rulewski,
Chief Executive Officer and Principal Executive Officer of the Company, certify,
pursuant to 18 U.S.C. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley
Act of 2002, that:

(1) The Report fully complies with the  requirements of section 13 (a) or 15 (d)
of the Securities Exchange Act of 1934; and

(2) The  information  contained in the Report fairly  presents,  in all material
respects, the financial condition and result of operations of the Company.


Date: November 18, 2005

By: /s/ Nigel Rulewski
- ----------------------------
Nigel Rulewski
CEO
(Principal Executive Officer



A signed  original of this written  statement  required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the  electronic  version of this written  statement
has been  provided  to the  Company  and will be  retained  by the  Company  and
furnished to the Securities and Exchange Commission or its staff upon request.